These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9693996)

  • 1. The relationship between plasma MHPG and NE: employing regression models in estimating centrally derived MHPG and peripheral NE turnover rate in panic disorder.
    Gurguis GN; Uhde TW
    J Psychiatr Res; 1998; 32(1):11-7. PubMed ID: 9693996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional origins of 3-methoxy-4-hydroxyphenylglycol in plasma: effects of chronic sympathetic nervous activation and denervation, and acute reflex sympathetic stimulation.
    Lambert GW; Kaye DM; Vaz M; Cox HS; Turner AG; Jennings GL; Esler MD
    J Auton Nerv Syst; 1995 Nov; 55(3):169-78. PubMed ID: 8801267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indices of noradrenergic output in depression.
    Siever LJ; Uhde TW; Jimerson DC; Lake CR; Kopin IJ; Murphy DL
    Psychiatry Res; 1986 Sep; 19(1):59-73. PubMed ID: 3786600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease.
    Raskind MA; Peskind ER; Halter JB; Jimerson DC
    Arch Gen Psychiatry; 1984 Apr; 41(4):343-6. PubMed ID: 6703854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noradrenergic response to intravenous yohimbine in patients with depression and comorbidity of depression and panic.
    Guthrie SK; Grunhaus L; Pande AC; Hariharan M
    Biol Psychiatry; 1993 Oct; 34(8):558-61. PubMed ID: 8274583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment.
    Charney DS; Heninger GR
    Arch Gen Psychiatry; 1985 May; 42(5):473-81. PubMed ID: 2985014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder.
    Coplan JD; Papp LA; Pine D; Martinez J; Cooper T; Rosenblum LA; Klein DF; Gorman JM
    Arch Gen Psychiatry; 1997 Jul; 54(7):643-8. PubMed ID: 9236548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noradrenergic function in generalized anxiety disorder, major depressive disorder, and healthy subjects.
    Sevy S; Papadimitriou GN; Surmont DW; Goldman S; Mendlewicz J
    Biol Psychiatry; 1989 Jan; 25(2):141-52. PubMed ID: 2539200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma MHPG levels in lactate and isoproterenol anxiety states.
    Pohl R; Ettedgui E; Bridges M; Lycaki H; Jimerson D; Kopin I; Rainey JM
    Biol Psychiatry; 1987 Sep; 22(9):1127-36. PubMed ID: 3651531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment.
    Charney DS; Heninger GR
    Arch Gen Psychiatry; 1985 May; 42(5):458-67. PubMed ID: 2859008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noradrenergic function and hypothalamic-pituitary-adrenal axis activity in primary unipolar major depressive disorder.
    de Villiers AS; Russell VA; Carstens ME; Aalbers C; Gagiano CA; Chalton DO; Taljaard JJ
    Psychiatry Res; 1987 Oct; 22(2):127-40. PubMed ID: 3120204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of clonidine on central and peripheral catecholamine metabolism.
    Martin PR; Ebert MH; Gordon EK; Linnoila M; Kopin IJ
    Clin Pharmacol Ther; 1984 Mar; 35(3):322-7. PubMed ID: 6199153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls.
    Gurguis GN; Uhde TW
    Psychoneuroendocrinology; 1990; 15(3):217-24. PubMed ID: 2255749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic autonomic failure: CSF and plasma 3-methoxy-4-hydroxyphenylglycol.
    Polinsky RJ; Jimerson DC; Kopin IJ
    Neurology; 1984 Jul; 34(7):979-83. PubMed ID: 6539879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of effect of anxiety on total plasma MHPG in depressed patients.
    Karege F; Bovier P; Hilleret H; Gaillard JM
    J Affect Disord; 1993 Jul; 28(3):211-7. PubMed ID: 8408983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma MHPG response to yohimbine treatment in women with hypoactive sexual desire.
    Piletz JE; Segraves KB; Feng YZ; Maguire E; Dunger B; Halaris A
    J Sex Marital Ther; 1998; 24(1):43-54. PubMed ID: 9509380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma 3,4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are insensitive indicators of alpha 2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers.
    Scheinin M; Karhuvaara S; Ojala-Karlsson P; Kallio A; Koulu M
    Life Sci; 1991; 49(1):75-84. PubMed ID: 1646924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of desmethylimipramine on the metabolism of norepinephrine.
    Zavadil AP; Ross RJ; Calil HM; Linnoila M; Blombery P; Jimerson DC; Kopin IJ; Potter WZ
    Life Sci; 1984 Sep; 35(10):1061-8. PubMed ID: 6482645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfate and glucuronide conjugates of 3-methoxy-4-hydroxyphenylglycol (MHPG) in urine of depressed patients: central and peripheral influences.
    Peyrin L; Pequignot JM; Chauplannaz G; Laurent B; Aimard G
    J Neural Transm; 1985; 63(3-4):255-69. PubMed ID: 4067598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between plasma and cerebrospinal fluid norepinephrine and dopamine metabolites in a nonhuman primate.
    Greene KA; Faull KF
    J Neurochem; 1989 Oct; 53(4):1007-13. PubMed ID: 2769251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.